Innoviva (INVA) EBIT (2010 - 2026)
Innoviva (INVA) recorded EBIT of $50.86 million in Q2 2026, up 4.3% from $48.75 million a year earlier and up 33.3% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Innoviva's EBIT came in at $162.58 million as of Jun 30, 2026, down 7.9% year-over-year; for FY2025, it came in at $163.75 million, down 1.9% from FY2024.
- Annual EBIT has a five-year compound annual growth rate of -12.6% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $166.87 million in FY2024 (+46.5%), $113.89 million in FY2023 (+58.8%), $71.7 million in FY2022 (-80.9%) and $375.1 million in FY2021 (+16.8%).
- The Q2 2026 figure is the highest quarterly EBIT since Q2 2024.
- On a year-over-year basis, EBIT rose in two of the last six quarters, with growth averaging 2.7%.
- Peak year-over-year performance for EBIT in the last five years was growth of 60.5% in Q1 2025, against a decline of 20.0% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $38.15 million (Q1 2026), $38.99 million (Q4 2025) and $34.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn | 50.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.86 Mn |
| Mar 31, 2026 | 38.15 Mn |
| Dec 31, 2025 | 38.99 Mn |
| Sep 30, 2025 | 34.58 Mn |
| Jun 30, 2025 | 48.75 Mn |
| Mar 31, 2025 | 41.43 Mn |
| Dec 31, 2024 | 43.14 Mn |
| Sep 30, 2024 | 43.24 Mn |
| Jun 30, 2024 | 54.69 Mn |
| Mar 31, 2024 | 25.81 Mn |
| Sep 30, 2023 | 75.77 Mn |
| Jun 30, 2023 | -9.63 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 82.55 Mn |
| Mar 31, 2022 | 77.73 Mn |
| Dec 31, 2021 | 104.53 Mn |
| Sep 30, 2021 | 94.55 Mn |
| Jun 30, 2021 | 96.54 Mn |
API Access
Innoviva EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();